vDPP
Behavioralvirtual Diabetes Prevention Program
NCT Number: NCT04195477
The goal of the proposed Implementation Research project is to assess the feasibility of and pathways for implementation of a virtually-delivered DPP (v-DPP) supported by community-based care coordination facilitated by community health workers (CHWs) and hospital-based community nurses (HCNs). The goal of the intervention is to improve body weight, blood pressure, diet quality, and physical activity levels among low-income individuals at risk for type 2 diabetes.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Griffin Hospital, Derby, Connecticut, United States
Specific aims and hypotheses:
Hypothesis: These efforts will identify individual and community needs, barriers, and resources affecting the feasibility of v-DPP implementation. In addition, strategies for facilitating the delivery of the v-DPP to low-income communities will be developed.
Hypothesis: The v-DPP facilitated by community-based care coordination will produce favorable RE-AIM outcomes. Factors influencing these outcomes will be explored as well.
Hypothesis: The v-DPP, facilitated by community-based care coordination provided by CHWs and HCNs, will improve body weight, blood pressure, diet quality, and physical activity levels in the study communities.
Hypothesis: The implementation approach will be packaged, including strategies for implementation in different settings and related costs, providing a process for implementation in other low-income communities in our region and nationally.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
virtual Diabetes Prevention Program
Time frame: 16 weeks and 12 months
Body mass index (BMI) will be measured as a participant's weight in kilograms divided by his/her height in meters squared. Height will be collected by a RA/CHW/HCN using a stadiometer at baseline and at 4 weeks.
Time frame: 16 weeks and 12 months
Waist circumference in centimeters will be collected at baseline and at 4 weeks.
Time frame: 16 weeks and 12 months
Total cholesterol (Tchol) will be collected at baseline and at 4 weeks.
Time frame: 16 weeks and 12 months
Triglycerides (TG) will be collected at baseline and at 4 weeks.
Time frame: 16 weeks and 12 months
High-density lipoprotein (HDL) will be collected at baseline and at 4 weeks.
Time frame: 16 weeks and 12 months
Dietary quality will be assessed at baseline and 4 weeks for the study. Participants will complete a 24-hour dietary recall using a web-based Automated Self-Administered 24-Hour Recall (ASA24) (available from the National Cancer Institute at ttp://riskfactor.cancer.gov/tools/instruments/asa24/), which will guide them through the process of completing the recall. Diet quality based on the information provided will be assessed using the Healthy Eating Index 2010 (HEI-2010).
Time frame: 16 weeks and 12 months
Physical activity level (PA) will be assessed at baseline and 4 weeks for the study. The International Physical Activity Questionnaire (IPAQ). It is a comprehensive tool containing information on weekly household and yard-work activities, occupational activity, transport, leisure time physical activity, and sedentary behavior.
Yale University
Other
Improving Health in Low Income Communities: Virtual Delivery of a Diabetes Prevention Program Facilitated With Community Care Coordination
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06965075
Behavior, Behavioral Symptoms
San Francisco, California, United States
View Trial DetailsNCT04709549
Behavior, Behavioral Symptoms
San Francisco, California, United States
View Trial DetailsNCT05130593
Diabetes Prevention
Baton Rouge, Louisiana, United States
View Trial DetailsNCT02458027
Diabetes Prevention, Obesity Prevention
Winnipeg, Manitoba, Canada
View Trial Details